Background and aims
Introduction
Endoglin (Eng) is a 180-kDa homodimeric transmembrane glycoprotein, predominantly expressed in endothelial cells and playing a key role in cardiovascular development, angiogenesis, vascular remodeling and homeostasis [1, 2] . Eng is a co-receptor of the TGF-β receptor complex that interacts with TGF-β signaling receptors types I and II, and modulates cellular responses to TGF-β [3, 4] .
A soluble form of endoglin (sEng) is released from membrane bound Eng by proteolytic cleavage of its extracellular domain during endothelial injury or inflammation and subsequently sEng enters the blood circulation [5, 6] . Increased levels of sEng in plasma have been detected in patients with cardiovascular-related disorders like atherosclerosis [7, 8] , hypercholesterolemia [9] , hypertension, type II diabetes mellitus [10] and preeclampsia, where sEng levels correlate with disease severity [11] . Because all these pathological conditions are associated with endothelial dysfunction, it was suggested that high levels of sEng could be considered as a biomarker of endothelial dysfunction and cardiovascularrelated pathologies [12] .
Endothelial dysfunction is considered as the first and key step in the development of atherosclerosis. It is mostly associated with an impairment of endothelial-dependent vasodilation mediated by nitric oxide (NO). The endothelium has a constitutive expression of NO catalyzed by endothelial nitric oxide synthase (eNOS) that is one of the most important factors leading to normal vascular relaxation [13, 14] . Decreased expression of membrane Eng was demonstrated to be associated with lower NO-dependent vasodilation and reduced expression of eNOS [15] [16] [17] . In addition, it has been reported that Eng affects eNOS expression in endothelial cells via Smad2/3 transcription factors without involvement of TGF-β [18] . In addition, vascular endothelium controls vasodilation respectively vasoconstriction via myosin light chain kinase signaling in smooth muscles [19] . 4 The phosphorylation of myosin light chain (MLC) is the main regulatory mechanism of smooth muscle contraction [20] .
It is of interest to mention, that sEng was demonstrated to have potentially opposite effects on vascular endothelium as compared to membrane endoglin, resulting in inhibition of eNOS-dependent vasodilation [11] or higher expression of cell adhesion molecules [21] . Our previous studies in mice were focused on possible effects of sEng in the atherosclerosis prone aorta under the conditions of chow and high fat diet [22, 23] . sEng alone did not induce any signs of endothelial dysfunction [23] but combination with hypercholesterolemia resulted in development of pro-inflammatory phenotype. However, this pathological condition was not accompanied by the induction of endothelial dysfunction [22] .
Thus, in this study, we used the same transgenic mouse model expressing human sEng (Sol-Eng + ) [24] to reveal whether longer exposure to sEng and hypercholesterolemia will result in functional alteration of aorta. We hypothesized that sEng aggravates endothelial and vessel wall dysfunctions in aorta that are primarily triggered by high fat diet. 
Materials and methods

Animals and Experimental Design
Transgenic mice overexpressing human sEng (Sol-Eng
background were generated at the Genetically Modified Organisms Generation Unit (University of Salamanca, Spain), as previously described [24] . Six-month-old female mice with low levels of sEng fed a chow rodent diet (Sol-Eng + low chow) were used as control mice for biochemical analysis only. All other experiments were performed with three-monthold female mice with high plasma levels of sEng (Sol-Eng + high HFD) (mice with sEng levels higher than 100 ng/mL were considered as Sol-Eng + high HFD) and their age matched female transgenic littermates with low levels of sEng (Sol-Eng + low HFD) fed a high fat rodent diet containing 1.25% of cholesterol and 40% of fat (Research Diets, Inc., USA) for the following 6 months. The animals were kept in controlled ambient conditions in a temperature-controlled room with a 12h-12h light-dark cycle with constant humidity and had access to tap water ad libitum. No weight differences were observed among experimental groups.
All experiments were carried out in accordance with the standards established in the directive of the EU (2010/63/EU) and all procedures were approved by the Ethical Committee for the protection of animals against cruelty at Faculty of Pharmacy, Charles University (Permit Number: 21558/2013-2), and the Bioethics Committee of the University of Salamanca (Permit Number: 006-201400038812). Mice were anesthetized with ketamine/xylazine, and all efforts were made to minimize the suffering of the animals.
ELISA and Luminex assay
Blood samples were obtained from vena cava inferior and plasma levels of human sEng were determined by means of Human Endoglin/CD105 Quantikine ELISA Kit (R&D Systems, MN, USA) according to the manufacturer's instructions. Due to the specificity of 6 the transgenic mouse model, the methodology of human sEng evaluation in plasma had to be adjusted for our studies (300-fold dilution of murine samples compared to typical 4-fold dilution in standard human studies). Plasma levels of intercellular adhesion molecule 1 (ICAM-1), monocyte chemoattractant protein 1 (MCP-1), P-selectin and tumor necrosis factor α (TNFα) were determined by means of Mouse Premixed Multi-Analyte Magnetic Luminex
Kit (R&D Systems, MN, USA), according to the manufacturer's protocol. Concentrations were reported as nanograms per milliliter (ng/mL) for human sEng and picograms per milliliter (pg/mL) for ICAM-1, MCP-1, P-selectin and TNFα.
Biochemical analysis
Total concentration of plasma cholesterol was measured enzymatically by conventional enzymatic diagnostic kits (Lachema, Brno, Czech Republic) and spectrophotometric analysis (cholesterol at 510 nm, ULTROSPECT III, Pharmacia LKB Biotechnology, Uppsala, Sweden). Concentrations were reported as millimolar (mmol/L).
Immunohistochemistry
Serial sections of heart were cut until the aortic root containing semilunar valves together with aorta appeared. From this point on, serial cross-sections (7 μm) were cut on a cryostat and placed on gelatin-coated slides. For fluorescence staining of macrophages/monocytes, slides were incubated with rat anti-mouse monoclonal primary antibody macrophages/monocytes (MOMA-2) (Bio-Rad Laboratories, CA, USA) at a dilution of 1:100 in 1% BSA for 1 hour in room temperature. Goat anti-rat secondary antibody marked with green fluorochrome DyLight488 (Jackson ImmunoResearch, USA) was used at a dilution of 1:100 in 1% BSA for 30 minutes at room temperature to detect macrophages. For nuclear counterstaining, blue-fluorescent DAPI nucleic acid staining was used (Invitrogen, Czech Republic).
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Photo documentation and image digitizing were performed by using a digital firewire camera Pixelink PL-A642 (Vitana Corporation, Ottawa, Canada) and a VDS Vosskuehler CD-1300QB monochromatic camera (VDS Vosskühler GmbH, Germany) for fluorescence with image analysis software NIS (Laboratory Imaging, Czech Republic).
Functional analysis of vascular reactivity
On the day of the experiment, mice were anesthetized i.p. with a mixture of ketamine (100 mg/kg) and xylazine (16 mg/kg) and thoracic aortas were quickly removed, carefully dissected from surrounding tissue and immediately placed in Krebs-Henseleit solution.
Connective and adipose tissue in the adventitia was carefully removed, and the descending For the endothelium-independent relaxation, a cumulative concentration-dependent response for sodium nitroprusside (SNP, 0.001-1 µM) was induced. Effect of NO production on vascular reactivity was measured by analyzing the Ach effect in the presence of the nitric oxide synthase inhibitor N (ω)-nitro-L-arginine methyl ester (L-NAME, 300 μM). Between 8 each concentration-response curve, the rings were washed three times with Krebs-Henseleit solution and left to stabilize.
Western blot analysis
Samples of aortas were homogenized in RIPA lysis buffer (Sigma-Aldrich, St. Louis, USA) supplemented with protease (SERVA Electrophoresis, Germany) and phosphatase (Thermo Fisher Scientific Inc., IL, USA) inhibitors, as described previously [23] .
Homogenates (20 µg of total protein) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis, transferred onto PVDF membrane (Millipore, NY, USA), and incubated with appropriate antibodies (Supplemental Table 1 ). Horseradish peroxidaseconjugated secondary antibodies were from Sigma-Aldrich Co. (St. Louis, USA) as described previously [23] . Membranes were developed using enhanced chemiluminescent reagents (Thermo Fisher Scientific Inc., IL, USA) and exposed to X-Ray films (Foma, Czech Republic). Densitometric quantification of immunoreactive bands was performed by image analysis software NIS (Laboratory Imaging, Prague, Czech Republic). Protein specific signals in each lane were normalized to GAPDH signal.
Statistical analysis
The statistical analysis was performed by GraphPad Prism 7.0 software (GraphPad Software, Inc., CA, USA). All data are presented as mean ± S.E.M. concentration, was used in concentration 60 mM to assess the contractile maximal response.
As shown in Fig. 2A (Fig. 2D ) as well.
To evaluate whether vasodilation induced by acetylcholine was entirely eNOS-dependent, L-NAME as a direct inhibitor of eNOS was used. The effect of L-NAME on Ach-induced relaxation in PGF2α pre-constricted vessels reached significantly higher values of vasodilation at 1 µM Ach (40.90 ± 15.10% vs. 3.14 ± 1.30%, respectively) in Sol-Eng + high 11 HFD compared to Sol-Eng + low HFD mice (Fig. 2E) , suggesting that Ach-induced vasodilation response was accompanied by additional compensatory NO releasing mechanisms. It is of interest to mention that endothelium-dependent relaxation and endothelium-independent relaxation induced by SNP were significantly lower compared to our previous study in mice fed by high fat diet for three months [22] suggesting alteration of endothelial function by high fat diet in both studied groups in the paper.
Sol-Eng + high HFD mice do not develop pro-inflammatory phenotype in aorta
Western blot analysis of inflammatory markers related to endothelial dysfunction was performed. No significant differences between Sol-Eng + high HFD and Sol-Eng + low HFD mice in the expression of VCAM-1 (Fig. 3A) , ICAM-1 ( Fig. 3B ) and P-selectin (Fig. 3C) were observed.
The activation of nuclear factor kappa B (NF-κB) is reported as a ratio of phosphorylated (active) form expression to the non-phosphorylated form expression. The activation of NF-κB was not significantly different between Sol-Eng + high HFD and Sol-Eng + low HFD mice as well (Fig. 3D ).
Endoglin/eNOS signaling is altered in Sol-Eng + high HFD mice
Regarding the fact that membrane endoglin signaling via Smad2/3 transcription factor was previously shown to be important in endothelial function, we analyzed the expression of membrane Eng, eNOS and its phosphorylated form p-eNOS Ser1177, as well as Smad2/3 and its phosphorylated form.
The expressions of eNOS and p-eNOS (Ser1177), Smad2/3 and pSmad2/3, are reported as a ratio of the phosphorylated form expression to its non-phosphorylated form expression. Significantly reduced expressions of membrane Eng (to 73%; Fig. 4A ), p-eNOS Ser1177/e-NOS (to 55%; Fig. 4B ) and pSmad2/3/Smad2/3 (to 63%; Fig. 4C Expression of prostaglandin I2 synthase (PTGIS) also known as prostacyclin synthase (Fig. 5B ) and cyclooxygenase type 2 (COX-2) (Fig. 5C ) was measured to reveal potential compensation mechanisms leading to release of NO under pathological conditions. However, no statistical significant changes were observed in the expressions of either PTGIS or COX-2.
Immunohistochemical analysis of macrophages in aortic sections
Sixty aortic sections in thirty slides were evaluated per each experimental group. The aortic sections did not develop alteration in histological structure with respect to possible fat accumulation (fatty streaks) or other visible changes in the vessel wall (data not shown). In addition, no infiltration of macrophages in the vessel wall was observed either in Sol-Eng + high HFD mice or Sol-Eng + low HFD mice. ApoE/LDLR double knockout mice aortic section was used as a positive control for macrophage staining in aorta (Supplemental Fig. 1 ).
Discussion
Hypercholesterolemia, atherosclerosis, type II diabetes mellitus and hypertension are pathological disorders that were demonstrated to be related to increased levels of sEng, suggesting that sEng could be a potential biomarker of endothelial alteration, which is typical for above mentioned diseases [12] . However, the question is whether sEng might also modulate the function of membrane-bound endothelial endoglin and endothelial function in these pathological conditions, which are usually accompanied by the hypercholesterolemia.
Of note, hypercholesterolemia is associated with increased levels of oxysterols, which via LXR nuclear receptors can upregulate the expression of both membrane-bound and soluble endoglin [24, 25] . Here we demonstrate for the first time that long exposure to high sEng levels and mild hypercholesterolemia (induced by high fat diet) result in endothelial and vessel wall dysfunction in aorta and altered membrane endoglin/eNOS signaling.
sEng is chipped from the extracellular domain of the membrane-bound endoglin, which is expressed by endothelial cells and smooth muscle cells in blood vessels [6] . In addition, several papers demonstrated that sEng can directly affect the function of blood vessels. Thus, it has been shown that administration of recombinant sEng led to impaired binding of TGF-ß1 to its receptor and subsequently to an inhibition of eNOS-dependent vasodilation in rat renal microvessels and mesenteric vessels, suggesting possible hypertensive effects of sEng [11] . It is of interest to point out that mice treated with adenovirus expressing sEng had induction of endothelial dysfunction profile in endothelium of mesenteric venules, which was characterized by higher expression of cell adhesion molecules and impaired vasodilation [21] . As these studies were not actually related to atherosclerosis prone blood vessels, we performed the first study that was targeted to elucidate potential effect of high levels of sEng on aorta [23] . By using transgenic mouse model expressing human sEng (Sol-Eng + ) that shows many symptoms of preeclampsia, such 14 as hypertension, small pup size, proteinuria and renal damage [24] , we failed to detect any harmful effect of sEng on aortic function or expression of endothelial dysfunction related markers [23] . These results are in line with a recent paper showing that sEng does not affect TGF-β signaling alone, but rather together with other TGF-β receptors [26] . To further pursue this line of research, we decided to combine high fat diet with high levels of sEng in order to mimic situation in patients with atherosclerosis, type II diabetes mellitus and hypertension where hypercholesterolemia is very common. The results of Jezkova et al. paper showed that combination with high fat diet induces a pro-inflammatory phenotype in aorta with increased expression of NF-κB and cell adhesion molecules. Surprisingly, we also found a preservation of aortic function in mice having high sEng plasma levels [22] . Despite these controversial results, we demonstrated that hypercholesterolemia in combination with high plasma levels of sEng deserves further study. Sol-Eng + low HFD mice showed lower levels of all measured parameters when compared to our previous experiment with mice on chow diet [23] or in mice fed three months with high fat diet [22] , suggesting that administration of high fat diet for six months impairs the function to atherosclerosis-intact aorta. So, the only difference between these groups was in the levels of human sEng. In general, there is a high level of homology between mouse and human sEng (99% sequence overlap, 69% identity) [27, 28] and mouse models used by our group showed several times that human sEng can affect mouse endoglin signaling [22, 24] . As mentioned above, there are controversial findings on whether sEng interferes with TGF-β signaling [26, 29] . However, it was demonstrated that sEng antagonizes the effects of membrane endoglin that is highly expressed by endothelial and smooth muscle cells [30] . In addition, we found that protein levels of mouse membrane endoglin are decreased in Sol-Eng + high HFD mice compared to Sol-Eng + low HFD mice (Fig. 4A) , suggesting a complex and regulatory interplay between the two forms of endoglin. Interestingly, membrane endoglin was shown to be related to a proper function of eNOS and NO-dependent vasodilatation [15, 18] , whereas its reduced expression resulted in an impaired endothelium-dependent vasodilatation [15] . In addition, membrane endoglin increases eNOS expression via Smad2/3 transcription factor directly without cooperation with TGF-β1 [18] . Indeed, Western blot analysis revealed reduced expression of membrane endoglin, phosphorylated Smad2/3 and phosphorylated eNOS Ser1177 in Sol-Eng + high HFD mice in this study. Thus, we might propose that sEng 16 aggravates endothelial and vessel wall dysfunction in aorta via interference with membrane endoglin/Smad2/3/eNOS dependent pathway.
Functional analysis of aorta showed activation of some compensatory reaction in aorta of Sol-Eng + high HFD mice (measured by L-NAME as direct inhibitor of eNOS). Indeed, there are several ways that could explain this compensatory reaction including activation of COX-2, PGs, or EDHF [31] [32] [33] . However, COX-2 and PTGIS protein expression in aorta did not differ between studied groups in this study. On the other hand, we cannot rule out the involvement of COX-2 and PTGIS activity in the compensation based on the protein expression analysis, therefore no clear conclusion can be drawn from these results. In addition, we must point out that we have not deepened more into this compensatory mechanism as this was not the primary goal of this study. In our view, this is a complex issue and further and independent studies are necessary to address this point, which is out of the scope of the manuscript.
We also focused on potential molecular mechanism related to altered vasoconstriction response in Sol-Eng + high HFD mice. Vasodilation and vasoconstriction is regulated via myosin light chain kinase signaling in smooth muscle cells [19] . KCl acts as a calcium sensitizer and membrane depolarization occurs after its administration. KCl activates voltagedependent calcium channel and this leads to an increased intracellular calcium concentration and subsequently to activation of myosin light chain kinase (MLCK) [34] . MLCK is a Ca 2+ /calmodulin-dependent protein kinase responsible for myosin phosphorylation and the phosphorylation of myosin light chain (MLC) is the main regulatory mechanism of smooth muscle contraction [20] . So, there is a direct relation between activity of MLCK, degree of MLC phosphorylation and therefore ability of smooth muscle contraction [35] . A key aspect of endothelial dysfunction development is the activation of vascular inflammation with increased expression of cell adhesion molecules [36] . Surprisingly, we did not detect any significant differences in the expression of VCAM-1, ICAM-1, P-selectin and pNF-κB/NF-κB in both aorta and blood between both studied groups as we showed in our previous paper [22] . One possible explanation why we do not see the differences in VCAM-1, ICAM-1, P-selectin and pNF-κB/NF-κB expressions might be in the fact that mice are under long term high fat diet (6 months) in this study and the expression levels of these proteins might be high enough in both groups (especially considering the fact that both groups of mice have aggravated function of endothelium when compared with Jezkova et al. paper). Thus, different age of mice (9 months), different exposure to high fat diet (6 months) and soluble endoglin (9 months) in this study when compared to Jezkova et al paper (age of mice 6 months, high fat diet 3 months and soluble endoglin 6 months) could be responsible for the different results that we obtained [22] . On the other hand, we measured other pro- investigating atherogenesis in the mice with high levels of soluble endoglin do not appear yet to be feasible. Moreover, we would like to also point out that, we measured blood pressure in Nemeckova et al paper [37] . The measurements of arterial pressure by tail-cuff method showed that systolic pressure in male and female Sol-Eng+ mice is higher than that of control mice. Higher blood pressure in mice with high soluble endoglin is the key feature of this mouse model that we have established before.
In conclusion, we demonstrated that long-term hypercholesterolemia (induced by high fat diet) combined with high plasma levels of sEng results in the aggravation of endothelial and vessel wall dysfunction in aorta with possible alteration of membrane endoglin/eNOS signaling. Thus, it is necessary to consider sEng as not only a biomarker of cardiovascular diseases but also as a potential co-inducer of vascular alterations especially in combination with other risk factors of cardiovascular diseases including hypercholesterolemia.
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